INNOSCIENCE (HKEX: 02577) shares plummeted 5.13% during Tuesday's intraday session.
The decline comes as profit-taking emerges following a sharp rally driven by the company's landmark patent victory over Infineon. Persistent selling pressure from the company's H-share full circulation continues to weigh on sentiment, with approximately 374 million previously unlisted domestic shares converted to tradable H-shares. Additionally, STMicroelectronics' cornerstone allocation of approximately 12.59 million shares is set to unlock soon, further dampening near-term appetite. Institutional shareholders including China Merchants Bank International have recorded multiple recent disposals according to HKEX filings.